{
  "id": 9554113,
  "title": "Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?",
  "url": "https://urgent.news/2026/09/24/bristol-myers-squibb-vs-pfizer-which-healthcare-stock-is-a-better-buy",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-24T11:56:09.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/coverage/better-buy/2026/09/24/bristol-myers-squibb-vs-pfizer-which-healthcare-stock-is-a-better-buy-in-2026/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "Investors in the healthcare sector frequently compare the merits of industry giants like Bristol Myers Squibb (BMY) and Pfizer (PFE), especially considering their dividend yields and drug pipelines. Both companies stand to be affected by patent expirations of their flagship drugs. Bristol Myers Squibb concentrates on enhancing its existing strengths in specialized oncology and immunology, while Pfizer is leveraging its substantial cash reserves accumulated during the pandemic to enter emerging, high-growth therapeutic sectors.\n\nBristol Myers Squibb is dedicated to developing groundbreaking therapies for severe diseases, with a primary emphasis on oncology, hematology, and neuroscience. The company's latest annual report, filed with the SEC, underscored its leadership in cancer treatment. Bristol Myers Squibb maintains strategic alliances with Merck (MRK) and Zai Lab (ZLAB) to develop a range of products. The company has recently concluded its manufacturing collaboration with Cellares, aiming to streamline its production processes. Bristol Myers Squibb distributes its treatments via direct sales teams and partnerships with international distributors.",
  "summary": "Both face patent cliffs and pay generous dividends, but only one of them can tell you where its next wave of growth is coming from.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?",
        "url": "https://urgent.news/2026/09/24/bristol-myers-squibb-vs-pfizer-which-healthcare-stock-is-a-better-buy-9554922",
        "published": "2026-09-24T12:16:09.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}